{"drugs":["Protirelin","Thyrel TRH"],"mono":{"0":{"id":"491123-s-0","title":"Generic Names","mono":"Protirelin"},"1":{"id":"491123-s-1","title":"Dosing and Indications","sub":{"0":{"id":"491123-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Disorder of pituitary gland; Diagnosis:<\/b> 200 to 500 mcg IV<\/li><li><b>Disorder of thyroid gland; Diagnosis:<\/b> 500 mcg (range 200 to 500 mcg) IV<\/li><\/ul>"},"1":{"id":"491123-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Disorder of thyroid gland; Diagnosis:<\/b> (6 to 16 y of age) 7 mcg\/kg IV; MAX dose: 500 mcg<\/li><li><b>Disorder of thyroid gland; Diagnosis:<\/b> (up to 6 y of age) 7 mcg\/kg IV have been used, however, experience in this age group is limited<\/li><\/ul>"},"3":{"id":"491123-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Disorder of pituitary gland; Diagnosis<\/li><li>Disorder of thyroid gland; Diagnosis<\/li><\/ul>"}}},"3":{"id":"491123-s-3","title":"Contraindications\/Warnings","sub":[{"id":"491123-s-3-9","title":"Contraindications","mono":"hypersensitivity to protirelin<br\/>"},{"id":"491123-s-3-10","title":"Precautions","mono":"<ul><li>adrenocortical drugs; it is not recommended to withdraw maintenance doses used in the therapy of known hypopituitarism<\/li><li>chronic administration of levodopa has been reported to inhibit the TSH response to protirelin<\/li><li>thyroid hormones reduce the TSH response to protirelin<\/li><li>transient changes in blood pressure frequently occur immediately following administration; do not administer to patients in whom marked, rapid changes in blood pressure would be dangerous unless the potential benefit clearly outweighs the potential risk<\/li><\/ul>"},{"id":"491123-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"491123-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"491123-s-4","title":"Drug Interactions","sub":{"2":{"id":"491123-s-4-15","title":"Moderate","mono":"<ul><li>Cyproheptadine (probable)<\/li><li>Thioridazine (probable)<\/li><\/ul>"}}},"5":{"id":"491123-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Hypertension, Hypotension, Lightheadedness<\/li><li><b>Dermatologic:<\/b>Flushing<\/li><li><b>Gastrointestinal:<\/b>Abdominal discomfort, Bad taste in mouth, Nausea, Xerostomia<\/li><li><b>Neurologic:<\/b>Headache<\/li><li><b>Renal:<\/b>Urgent desire to urinate<\/li><\/ul><b>Serious<\/b><ul><li><b>Neurologic:<\/b>Seizure, In patients with predisposing conditions (rare)<\/li><li><b>Ophthalmic:<\/b>Amaurosis, In patients with pituitary tumors<\/li><\/ul>"},"6":{"id":"491123-s-6","title":"Drug Name Info","sub":{"0":{"id":"491123-s-6-17","title":"US Trade Names","mono":"Thyrel TRH<br\/>"},"2":{"id":"491123-s-6-19","title":"Class","mono":"Diagnostic Agent, Thyroid Function<br\/>"},"3":{"id":"491123-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"491123-s-7","title":"Mechanism Of Action","mono":"<ul><li>Systemic: Diagnostic aid (thyroid function)-Like naturally occurring thyrotropin-releasing hormone (TRH), protirelin stimulates release of thyroid-stimulating hormone (TSH) from the anterior pituitary. As a result, protirelin can be used to detect an increase in or blunting of TSH response due to a variety of medical conditions or to confirm adequate suppression of TSH response by administration of thyroid hormones. <\/li><li>Protirelin appears to increase plasma growth hormone concentrations in some acromegalic patients. It also increases serum prolactin concentrations. <\/li><\/ul>"},"8":{"id":"491123-s-8","title":"Pharmacokinetics","sub":{"3":{"id":"491123-s-8-26","title":"Excretion","mono":"Systemic: Renal <br\/>"},"4":{"id":"491123-s-8-27","title":"Elimination Half Life","mono":"Systemic: 5 min <br\/>"}}},"10":{"id":"491123-s-10","title":"Monitoring","mono":"monitor blood pressure before drug is administered and at frequent intervals during the first 15 minutes after injection<br\/>"},"13":{"id":"491123-s-13","title":"Clinical Teaching","mono":"<ul><li>Instruct patient to rise slowly from a sitting\/supine position, especially within 15 min after drug administration, as drug may cause transient changes in blood pressure.<\/li><li>This drug may cause light-headedness, flushing, abdominal discomfort, bad taste in mouth, nausea, xerostomia, headache, or urgent desire to urinate.<\/li><\/ul>"}}}